An Orally Active Allosteric GLP-1 Receptor Agonist Is Neuroprotective in Cellular and Rodent Models of Stroke

Diabetes is a major risk factor for the development of stroke. Glucagon-like peptide-1 receptor (GLP-1R) agonists have been in clinical use for the treatment of diabetes and also been reported to be neuroprotective in ischemic stroke. The quinoxaline 6,7-dichloro-2-methylsulfonyl-3-N-tert- butylamin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huinan, Liu, Yunhan, Guan, Shaoyu, Qu, Di, Wang, Ling, Wang, Xinshang, Li, Xubo, Zhou, Shimeng, Zhou, Ying, Wang, Ning, Meng, Jingru, Ma, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749391/
https://www.ncbi.nlm.nih.gov/pubmed/26863436
http://dx.doi.org/10.1371/journal.pone.0148827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749391/
https://www.ncbi.nlm.nih.gov/pubmed/26863436
http://dx.doi.org/10.1371/journal.pone.0148827

Ejemplares similares